Usefulness of FIB-4 index and ALT at 1 year of nucleos(t)ide analog treatment for prediction of hepatocellular carcinoma in chronic hepatitis B patients.
Jun InoueTakehiro AkahaneTomoo KobayashiOsamu KimuraKosuke SatoMasashi NinomiyaTomoaki IwataSatoshi TakaiNorihiro KisaraToshihiro SatoFutoshi NagasakiMasahito MiuraTakuya NakamuraTeruyuki UmetsuAkitoshi SanoMio TsuruokaMasazumi OnukiSatoko SawahashiHirofumi NiitsumaAtsushi Masamunenull nullPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2023)
FIB-4≥1.58 and ALT≥31 at 1 year of NA were an independent risk factor for HCC development, and a score using these factors stratified the risk of HCC. This article is protected by copyright. All rights reserved.